CN Patent

CN101431982A — 口服液体组合物

Assigned to Rosemont Pharmaceuticals Ltd · Expires 2009-05-13 · 17y expired

What this patent protects

一种适合于口服给药的混悬液，包含辛伐他汀、至少一种助悬剂和至少一种防腐剂，其中至少90wt％辛伐他汀颗粒的直径小于100μm。本发明也包括混悬液的应用及混悬液的制备方法。

USPTO Abstract

一种适合于口服给药的混悬液，包含辛伐他汀、至少一种助悬剂和至少一种防腐剂，其中至少90wt％辛伐他汀颗粒的直径小于100μm。本发明也包括混悬液的应用及混悬液的制备方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN101431982A
Jurisdiction
CN
Classification
—
Expires
2009-05-13
Drug substance claim
No
Drug product claim
No
Assignee
Rosemont Pharmaceuticals Ltd
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.